Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate. [PDF]
Torkildsen Ø +3 more
europepmc +1 more source
Correction to "Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney Disease". [PDF]
europepmc +1 more source
A novel therapeutic approach to adrenocortical carcinoma repurposing fingolimod to target sphingolipid metabolism in metastatic disease. [PDF]
Subramanian C +8 more
europepmc +1 more source
Fingolimod as a Neuroprotective Agent in Ischemic Stroke: A Review of Preclinical and Clinical Evidence. [PDF]
Ciubotaru A +13 more
europepmc +1 more source
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis. [PDF]
Gavoille A +40 more
europepmc +1 more source
Fingolimod potentiates the antifungal activity of fluconazole against fluconazole-resistant <i>Candida auris</i>. [PDF]
Bae JH, Eom YB.
europepmc +1 more source
Association of cytokine levels with treatment duration and patient family history in Egyptian multiple sclerosis patients. [PDF]
Mohsen E +4 more
europepmc +1 more source
Therapeutic reactivation of hippocampal progenitors reverse cognition decline in mice with progressive brain demyelination. [PDF]
Nemati S +3 more
europepmc +1 more source
Fingolimod Improves Anxiety-like Behavior and Modulates Sphingosine-1-Phosphate Receptors Gene Expression in a Diabetic Mouse Model. [PDF]
Wencel PL +5 more
europepmc +1 more source
Rituximab-Induced Serum Sickness in Patients With Multiple Sclerosis: A Case Report and Literature Review. [PDF]
Sikkal A +4 more
europepmc +1 more source

